NF1 deficiency drives metabolic reprogramming in ER+ breast cancer
R. J. House, E. A. Tovar, C. J. Essenburg, P. S. Dischinger, A. E. Ellis, I. Beddows, R. D. Sheldon, E. C. Lien, C. R. Graveel, M. R. Steensma
This study investigates how NF1 deficiency affects metabolic reprogramming in ER+ breast cancer and identifies potential therapeutic synergies between metabolic and targeted inhibitors.
bioRxiv · Nov 24, 2023 · PreprintCancer Biology